Critically ill patients receiving renal replacement therapy (RRT) for acute kidney injury (AKI) have high reported intensive care unit (ICU) mortality. Blood culture (BC) collection practices in this population have to date been poorly characterised, specifically in regards to the influence of RRT on the clinical triggers for such an investigation. Utilising our electronic clinical information system, we conducted a retrospective observational study of patients admitted to a 30-bed tertiary level ICU and requiring RRT over a four-year period. Patients with a history of chronic kidney disease, prior RRT or ICU length-of-stay (LOS) <48 hours were excluded. Two hundred and thirty-one patients treated with RRT for AKI were identified. The observed median [interquartile range] BC collection rate in those having them drawn was 18 per 100 patient days, although 42% of the cohort had no BC drawn during their ICU stay. Application of RRT in the 24 hours prior to initial BC collection was associated with lower body temperatures, higher white cell counts and greater use of vasopressor therapy. Bloodstream infection (identified from the first BC) was associated with greater ICU and in-hospital mortality. We also observed a predominance of candidaemia in this cohort, despite the absence of neutropenia. This study provides unique data describing BC collection rates in a cohort of critically ill patients receiving RRT for AKI and at high risk of dying. Further study of temperature alteration, detection of bloodstream infection and outcome in patients receiving RRT is now warranted.
Acute kidney injury (AKI) is frequently encountered in the critically ill and is widely accepted to be associated with an increased risk of death 1 . More specifically, severe AKI requiring initiation of renal replacement therapy (RRT) will occur in approximately 4% of critically ill patients and has an associated mortality of 60-70% 2 . Despite often being associated with multiple organ failure and thus a high disease burden, AKI and/or RRT remain independent risk factors for mortality in this setting 3 . Although the mechanisms underlying this association remain poorly understood, recent research has confirmed that sepsis is a common finding in AKI and that the provision of dialysis is an independent risk factor 4 .
Despite early optimism that RRT would essentially maintain metabolic and electrolyte homeostasis until such time as native renal function had improved, it is now increasingly recognised that such therapies have a number of deficits and potential adverse effects 5, 6 . One such example is the lowering of body temperature during continuous RRT 7 , despite warming of both replacement and dialysate fluids 8 .
The implications of this decrease in body temperature in patients on RRT have not yet been the subject of thorough investigation, despite its significance being demonstrated in other clinical scenarios. For example, altered immune function and increased risk of infection have been demonstrated in hypothermic patients following haemorrhage 9 , cardiac arrest 10 , brain injury 11 and in surgical cohorts 12 . Furthermore, increased mortality has been observed in the setting of trauma 13 , sepsis 14 , inadvertent hypothermia in postoperative patients 15 and in critically ill patients receiving early fever suppression therapy 16 .
One potential mechanism by which reduction of body temperature may promote adverse outcomes in patients on RRT is by masking fever. While other indications are also recognised 17 , fever is a key trigger for suspicion of serious infection and the collection of blood cultures (BC) 18 . Fever suppression may therefore lower BC collection rates in those receiving RRT resulting in potentially inappropriate and delayed antimicrobial administration. This has significant ramifications for effectively managing bloodstream infection (BSI) [19] [20] [21] and may contribute to the excess mortality observed in patients developing sepsis in the setting of AKI 4 .
In this respect, an understanding of BC collection in this subgroup of critically ill patients is required prior to planning future investigation as currently there is no data documenting this practice in contemporary literature. The primary aims of this study were therefore to: a) quantify BC collection rates in patients receiving RRT for AKI; b) explore the clinical indicators (such as fever) for culture collection in this setting; and c) examine crude intensive care unit (ICU) and hospital mortality in this group. Finally, we report on trends in micro-organisms grown from BC in this cohort.
METHODS

Setting
This observational study was conducted in a 30bed tertiary level multidisciplinary ICU with ethical approval from the local institutional review board (HREC 2008/118) and a waiver for written informed consent. Major groups not represented include paediatrics, postoperative cardiac surgery patients and solid organ transplant recipients.
Patient selection
All patients admitted to the ICU between 1 January 2005 and 31 December 2008 were eligible for inclusion in the study. Prior to data collection, those patients with a history of chronic kidney disease (CKD), preexisting need for RRT or ICU length-of-stay (LOS) <48 hours were excluded. All remaining patients who required RRT for AKI during their ICU stay were included in the study. Details of routine care in the ICU are summarised below.
Temperature measurement
Hourly measures of body temperature are routinely undertaken. Measurements are most commonly obtained via a Foley-Temp™ or Mon-a-therm ® Thermistor temperature probe (Tyco Healthcare, Pleasanton, CA, USA) inserted into the bladder or nasopharynx. Occasionally, in less critically unwell patients, temperature may be measured by infrared tympanic thermometers (First Temp Genius ® , Sherwood Medical, St Louis, MO, USA). Although not always a true reflection of 'core' body temperature, the best available measurement was used in analysis. For the purposes of the study, fever was defined as a temperature >38.3°C 18 .
Blood culture collection
The ICU is staffed continuously by medical officers who, in accordance with current recommendations 18 , obtain blood cultures when infection is clinically suspected. A 20 ml sample of blood is drawn via aseptic venepuncture from a peripheral vein and placed in aerobic and anaerobic culture bottles (BacT/ALERT ® Biomerieux Inc, Durham, NC, USA). Two sets of blood cultures are typically collected. Specimens are processed by the central microbiology laboratory and time of culture collection (as documented by the collector), organisms cultured and time to culture growth are reported via an electronic laboratory database.
Renal replacement therapy
RRT in our ICU is provided solely as continuous veno-venous haemodiafiltration using the AN69 membrane and Aquarius ® (Edward Life Sciences, Sydney, Australia) haemodiafiltration machine. Blood flow rates are set at 250 ml/minute, dialysate and replacement fluid is warmed to 37°C and total effluent rates are approximately 30 ml/kg/hour. Vascular access employs a 20 cm 13.5 Fr Silicone Double Lumen Set (Edward Life Sciences, Sydney, Australia), inserted under aseptic technique into the internal jugular or femoral vein. The decision to initiate and cease therapy is entirely at the discretion of the treating clinician as no local policy exists to standardise this intervention. Current practice is, however, consistent with established guidelines 22 .
Data retrieval
All data was collected as part of routine care and recorded by clinical staff in the electronic clinical information system (CIS). The CIS database and medical charts were reviewed to determine demographic, illness severity, LOS, body temperature and RRT data. The electronic laboratory database was searched for presence of blood cultures, time of culture collection and culture results. Crossreferencing between data retrieved from the CIS and laboratory databases was carried out to record physiological data and presence of RRT around the time of culture collection. Where temperature at time of culture collection was not recorded, the most recent temperature prior to this event was utilised.
Only cultures collected at >48 hours after ICU admission were included in analysis. BSI was defined by the growth of one or more clearly pathogenic organisms identified using standard laboratory techniques. Where blood cultures grew multiple pathogenic micro-organisms, each was recorded and used individually in analysis. Organisms likely to be contaminants (such as coagulase negative Staphylococci) were disregarded if only found in one set of blood cultures. Pathogenic isolates that grew in subsequent cultures (within 14 days) were only included once in analysis.
Statistical analysis
Normality 
RESULTS
A total of 8198 patients were admitted over the study period. As illustrated in Figure 1 , 595 patients were excluded from analysis due to a history of CKD or prior RRT and a further 4870 were excluded due to a LOS <48 hours. Of the remaining 2733 eligible patients, 231 were identified as having had AKI requiring RRT. Table 1 summarises admission, demographic and outcome data for this cohort. A total of 475 cultures were drawn from 135 patients indicating that 42% (n=96) had no cultures obtained in the ICU. A comparison between these groups is shown in Table 2 . In those patients having cultures drawn, the median rate was 18 per 100 patient days, the mean temperature was 38.0 (1.04)°C and only 43.6% manifested fever at the time of culture collection.
Physiological and treatment data in the 24 hours preceding initial culture collection were available for 131 of 135 patients (97%). These data are presented in Table 3 . As demonstrated, recorded Each first blood culture was further subgrouped according to whether a pathogenic organism was isolated. This analysis is presented in Table 4 . As demonstrated, a 'positive' initial culture was associated with significantly higher ICU and inhospital mortality despite similar APACHE II scores, time to initiation of RRT, and duration of RRT. These patients were also older and displayed a trend towards greater application of RRT and vasopressor therapy in the preceding 24 hours and a longer ICU length-of-stay. Of note, there was a significantly longer delay to culture collection in those where BSI was identified.
A clearly pathogenic organism(s) was identified in 8.2% (39 of 475) of cultures overall, drawn from 31 patients. There was no association between 'positivity' and culture collection during RRT (P=0.146) or temperature at the time of culture collection ('positive' BC 37.9{1.05}°C vs 'negative' BC 38.1{1.04}°C, P=0.341). A total of 43 pathogenic organisms were isolated from the 39 blood cultures overall. The most commonly cultured pathogens were Candida spp. (23%), Pseudomonas spp. (16%) and Enterococcus faecalis (12%). Table 5 outlines the other organisms isolated. Of note, Candida spp. were also the most commonly identified pathogens (eight of 17) grown from initial blood cultures despite no patients manifesting neutropenia (data not shown).
DISCUSSION
This study has quantified BC collection in patients with AKI requiring continuous veno-venous haemodiafiltration, providing unique data for a specific cohort of ICU patients at high risk of dying. This data demonstrates that a significant number of patients do not have any BCs drawn in the ICU despite similar illness severity. However, as expected, culture collection is associated with a longer ICU length-of-stay and as such, future prospective studies investigating this area will need to consider that ~40% of the cohort may not undergo the required intervention, although in those having cultures drawn this practice is relatively common.
The influence of RRT on BC collection practices is more difficult to quantify. In the 24 hours preceding initial culture collection, application of RRT was associated with lower body temperatures, higher white cell counts and greater application of vasopressor therapy. This is in combination with very few cultures being obtained during RRT overall (<25%), and when actually drawn were associated with significantly lower body temperatures. The observed reduction in body temperature when 'on' RRT is in agreement with previous authors 7, 23 and suggests that, as illustrated, alterations in other physiological parameters or laboratory values are just as likely to activate culture collection in this setting. This also reinforces that BC collection is essentially a discretionary investigation and, as a primary endpoint, has significant methodological flaws.
In considering mortality in patients with BSI receiving RRT, Hoste and colleagues have previously documented high ICU and in-hospital mortality rates (approaching 60 and 70% respectively) although no significant difference in the risk of death was identified in those with BSI versus matched controls 24 . Of note, work by Kim et al suggests that BSI may only be an important predictor of mortality in patients with lower illness severity 25 , which may help to explain the association with BSI identified in our study. These findings are consistent with recent work by Mehta et al demonstrating increased mortality rates in dialysed patients developing sepsis pre and post-AKI 4 .
Of interest is the greater delay to initial BC collection in those with subsequent BSI. The reasons underlying this observation are not entirely clear, although a non-significant trend towards more frequent application of RRT in the 24 hours prior to culture collection was observed. As even minor delays in detection and commencement of appropriate antimicrobial therapy are associated with a significant increase in mortality 20, 26 , the potential impact of RRT clearly warrants further prospective study. However as dynamic changes in illness severity in the days preceding culture collection are also likely to influence this diagnosis 27 , significant planning will be required before undertaking any future research.
Comparison of the incidence of pathogens detected in our study to previously published data in general ICU cohorts is limited by our initial 48-hour exclusion criterion and by sample size. However a detectable and notable feature is the excess of candidaemia in patients on RRT. Such a finding is consistent with epidemiological studies recognising renal failure and haemodialysis as risk factors for candidaemia 28 , suggesting an increased susceptibility to such infections. In such a scenario a lack of antifungal administration 29 and even delays of less than 24 hours have been demonstrated to predict death in a number of studies 26, 27, 30, 31 . As such, any delay to BC collection, in addition to a high prevalence of candidaemia (for which empirical treatment is often inappropriate and delayed) 32 , may have significant implications for those receiving RRT in the ICU.
This study has a number of potential limitations. First, it employs retrospective data from a single centre only and therefore may reflect institutional practices rather than being representative of the effects of AKI and RRT on outcomes in the wider ICU population. Second, as there is limited data on BC collection rates and the influence of changes in body temperature in this setting, there are no readily available comparators. Identifying a control group is particularly problematic as the propensity to collect a BC is likely to be a reflection of dynamic changes in the ICU rather than admission and demographic data alone 27, 33 . Finally, we have utilised standard clinical temperature measurements that may not always be an accurate reflection of core values. This is difficult to control in a retrospective fashion and will require standardisation in any prospective study design. It must also be recognised that fever, despite regularly triggering investigation, has a poor specificity for infection in this setting.
CONCLUSION
This study has provided baseline data concerning BC collection rates for a cohort of critically ill patients at high risk of developing sepsis and dying in the ICU. Application of RRT in the 24 hours prior to initial BC collection was associated with lower recorded temperatures, although higher white cell counts and greater application of vasopressor therapy. BSI was associated with higher ICU mortality in addition to a greater delay to culture collection in those patients having them drawn. A high incidence of candidaemia was also identified overall and, in combination with the potential adverse effects of fever suppression, may contribute to the excess mortality observed.
